Contravisory Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Contravisory Investment Management's LLY Position: Q2 2026 in Review
Contravisory Investment Management reduced its Eli Lilly (LLY) stake by 1.9% in Q2 2026, selling an estimated $57.2K and leaving 2,955 shares worth $3.54M. The position accounts for 0.63% of the portfolio, ranked #41.
Contravisory Investment Management first reported a position in LLY in Q4 2014 and has held it in 20 quarters since. The position peaked at $8.8M in Q4 2022. 1,803 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Contravisory Investment Management held 2,955 shares of Eli Lilly worth $3.54M as of Q2 2026.
- Contravisory Investment Management sold 56 Eli Lilly shares in Q2 2026, an estimated $57.2K.
- Eli Lilly made up 0.63% of Contravisory Investment Management's portfolio in Q2 2026, its #41 holding.
- Contravisory Investment Management first reported a position in Eli Lilly in Q4 2014 and has held it in 20 quarters since.
- Contravisory Investment Management's Eli Lilly position peaked at $8.8M in Q4 2022.
- 1,803 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Contravisory Investment Management's 13F filing for Q2 2026, filed 9 Jul 2026.